One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v128.22.343.343
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 44 |
Affiliation: Memorial Sloan Kettering Cancer Center, Harvard University, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, University of Colorado Cancer Center, Sylvester Comprehensive Cancer Center, Presbyterian Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital, Cornell University, The University of Texas Southwestern Medical Center, Cleveland Clinic, Dana-Farber Cancer Institute, Agios Pharmaceuticals (United States), Institut Gustave RoussyEnasidenib (AG-221), a Potent Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, Induces Hematologic Responses in Patients with Myelodysplastic Syndromes (MDS)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
